Werewolf Therapeutics, Inc.·4

Jan 4, 4:30 PM ET

Karunatilake Chulani 4

4 · Werewolf Therapeutics, Inc. · Filed Jan 4, 2024

Insider Transaction Report

Form 4
Period: 2024-01-02
Karunatilake Chulani
Chief Technology Officer
Transactions
  • Award

    Stock Option (right to buy)

    2024-01-02+150,000150,000 total
    Exercise: $4.64Exp: 2033-12-31Common Stock (150,000 underlying)
Footnotes (1)
  • [F1]The option was granted on January 2, 2024 with a Vesting Commencement Date of January 1, 2024. The shares underlying the option vest in equal monthly installments over four years, commencing on the date that is one month following the Vesting Commencement Date and vesting monthly thereafter through January 1, 2028.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4